Is it relevant that intra-arterial chemotherapy may be effective for advanced pancreatic cancer?
Author:
Open Access
- 1 January 2007
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 13 (32) , 4306-4309
Abstract
Unresectable pancreatic cancers have an extremely dismal prognosis and chemoresistant nature. The treatment of pancreatic cancer is still problematic. Gemcitabine is a promising new agent that has been studied recently for palliation of advanced pancreatic cancer. However, the response rates have been highly variable, and are often irreproducible. To improve this low response rate, various treatments are needed because no standard treatment exists. Intra-arterial chemotherapy is considered to take advantage of the first pass effect of the drug, generating higher local drug concentrations in tumor cells with lower toxicity. Regional intra-arterial chemotherapy may provide high levels of cytostatic concentrations within the tumor and, simultaneously, a low rate of systemic side effects compared with systemic administration of anti-neoplastic drugs. Intra-arterial chemotherapy has been introduced as an alternative treatment for advanced pancreatic cancer. Further clinical trials of this method should be subjected to a prospective randomized controlled study for advanced pancreatic cancer.Keywords
This publication has 43 references indexed in Scilit:
- Clinical efficacy of intra-arterial pharmacokinetic chemotherapy with 5-fluorouracil, CDDP, gemcitabine, and angiotensin-II in patients with advanced pancreatic cancer.2007
- Fluorouracil and mitomycin for pancreatic cancerThe Lancet Oncology, 2005
- [A case of successful management of nonresectable pancreas cancer with liver metastasis by intra-arterial infusion chemotherapy with gemcitabine hydrochloride, 5-FU, CDDP and administration of tegafur/uracil].2004
- [A case of advanced gastric cancer with liver and intra-abdominal lymph node metastasis treated by hypertensive selective chemotherapy with pharmacokinetic modulating chemotherapy].2003
- Intra-arterial chemotherapy for unresectable pancreatic cancerAnnals of Oncology, 2000
- Cisplatin and protracted venous infusion 5-fluorouracil (CF) — good symptom relief with low toxicity in advanced pancreatic carcinomaAnnals of Oncology, 1995
- Results of resection for cancer of the exocrine pancreas: A study from the French Association of SurgeryBritish Journal of Surgery, 1994
- Factors influencing survival after pancreaticoduodenectomy for pancreatic cancerThe American Journal of Surgery, 1991
- Survival in 1001 Patients with Carcinoma of the PancreasAnnals of Surgery, 1987
- Vasoactive drugs and tumor blood flowBiorheology, 1984